Skip to main content

GLYCOMIMETICS INC

For the period ended Jun 13, 2025. Filed Jun 18, 2025.

View on SEC.gov

About this filing

A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.

Jun 13, 2025 · Filed Jun 18, 2025

Use the contents to explore the available documents and sections.

CBIO$13.54+4.6%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

EX-99.2 · 13. Segment Reporting

13. Segment Reporting

The Company has one reportable segment relating to the research and development of its research programs, CR-001, CR-002 and CR-003. The Company’s CODM, its Chief Executive Officer, manages the Company’s operations on a company-wide basis for the allocation of resources and the assessment of performance. The Company’s measure of segment profit or loss used to assess performance and allocate resources is net loss and comprehensive loss. Although the Company’s financial reporting package that is reviewed and approved by the CODM disaggregates significant expenses such as program-level external research and development costs, personnel costs including stock-based compensation expense, and professional and consulting fees, all decisions made by the CODM are based upon reviewing operating metrics and performance indications at the Company-wide level. The CODM uses net loss to evaluate loss generated from the Company’s business activities in deciding how to allocate company resources and monitoring budget versus actual results. Assets are also managed on a Company-wide basis.

The table below is a summary of the segment loss, including significant segment expenses (in thousands):

CR-001 external research and development costs$6,740
CR-002 external research and development costs1,370
CR-003 external research and development costs1,063
General and administrative personnel costs1,660
Research and development personnel costs1,431
Professional and consulting fees1,736
Other segment items (1)1,148
Net loss and comprehensive loss$15,148
(1)Other expense including interest expense and miscellaneous other expense offset by interest income
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.